SC 13D

Company

Cardiff Oncology, Inc.

Filed

July 2, 2020

Accession Number

0001193125-20-186682

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →